opioids titration

PreclinicalSmall molecule

CChinese University of Hong Kong

opioids titration is one of 45 small molecule programs targeting Advanced Cancer. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Advanced CancerCompleted

Advanced CancerPreclinical

Completed

Competition

Competitive Landscape

67 competitors in Advanced Cancer

#DrugCompanyPhaseTrials

Keytruda

Merck & Co.

Phase 2

12 2

Taxol

Teva

Phase 2

12 3

Gemzar

Johnson & Johnson

Phase 2

8 4

Camptosar

Pfizer

Phase 2

8 5

Opdivo

Bristol-Myers Squibb

Phase 2

6 6

Verzenio

Eli Lilly

Phase 2

4 7

Elunate

Takeda

Phase 2

1 8

Taxotere

AAvyxa

Phase 2

9 9

Torisel

PPrism Pharmaceuticals

Phase 2

5 10

Paraplatin

AAvyxa

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Advanced Cancer1 trial

Opioids Titration Study in Advanced Cancer Patients in Hong Kong

Completed·—·N/A·NCT03024515·2 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for opioids titration. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — opioids titration compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for opioids titration. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Chinese University of Hong Kong company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: CChinese University of Hong Kong

opioids titration

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Advanced Cancer1 trial

References

Drug Info

Quick Facts

Related News